Brind.

FDA approved Lupin's drug application, confirming its bioequivalence to AstraZeneca's reference drug.

3 reports, 2 independent Updated Sep 4
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
2
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

FDA approved Lupin's drug application, confirming its bioequivalence to AstraZeneca's reference drug.

How it developed

Newest first. Tap a step to see who reported it.
  1. U.S. FDA granted final approval for Pitolisant Tablets, confirming its bioequivalence to Wakix®.Sub-event
  2. FDA grants Lupin approval for a drug bioequivalent to AstraZeneca's RLD.1 source

Coverage

Newest first; wire copies grouped